Diabetes, Metabolic Syndrome and Obesity (May 2012)
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
Abstract
Shailendra KapoorMechanicsville, Richmond, VA, USAI read with great interest the article by Andukuri et al in a recent issue of your journal.1 The article makes compelling reading. Interestingly, research over the past few years has shown that in addition to its significant diabetic-modulating effects, alogliptin also exerts significant direct antiatherosclerotic effects.View original paper by Andukuri and colleagues